Home/Synchronicity Pharma/Shu Kurosaki, CPA

SK

Shu Kurosaki, CPA

Chief Financial Officer

Synchronicity Pharma

Therapeutic Areas

Oncology Neurology/Psychiatry

Synchronicity Pharma Pipeline

Drug	Indication	Phase
Sleep-wake Disorders	Sleep disturbances and autism-related behaviors in pediatric autism spectrum disorder (ASD)	Pre-clinical
Oncology	Microsatellite-stable colorectal cancer (MSS CRC)	Pre-clinical

Leadership Team at Synchronicity Pharma

Chief Executive Officer

Jamie Cope, Ph.D.

Chief Scientific Officer

Steve Kay, Ph.D., FRS, NAS

Founder, Director, and SAB Chair

View full Synchronicity Pharma profile